Bacterial compound (inhibitors, antagonists)-ProbeChem.com

Request The Product List ofBacterial Bacterial

Bacteria constitute a large domain of prokaryoticmicroorganisms. Antibiotics (also called antibacterials) are a type of antimicrobial drug used in the treatment and prevention of bacterial infections, a limited number of antibiotics also possess antiprotozoal activity. Together with vaccination, antibiotics have led to the near eradication of diseases such as tuberculosis in the developed world. However, their effectiveness and easy access have also led to their overuse, prompting bacteria to develop resistance.

A bactericidal activity of antibacterials may depend on the bacterial growth phase, and it often requires ongoing metabolic activity and division of bacterial cells. In vitro characterization of antibacterial activity commonly includes the determination of the minimum inhibitory concentration and minimum bactericidal concentration of an antibacterial. To predict clinical outcome, the antimicrobial activity of an antibacterial is usually combined with its pharmacokinetic profile, and several pharmacological parameters are used as markers of drug efficacy.

Cat. No.	Product Name	Information
PC-23925	V-161 EhV-ATPase inhibitor	V-161 is a potent, specific E. hirae Na+-transporting V-ATPase (EhV-ATPase) inhibitor with IC50 of 144 nM, blocks the function of Na+-transporting V-ATPase and preferentially inhibits the growth of enterococci.
PC-23867	BRD1401 OprH-LPS inhibitor	BRD1401 is a P. aeruginosa-specific inhibitor targeting outer membrane protein OprH-LPS interaction, increases membrane fluidity.
PC-23837	Mycobactin 1400-46-0	Mycobactin (Mycobactin M) is a conditionally essential molecule expressed by mycobacteria in iron-stress conditions.
PC-23818	Bio-AMS Biotin protein ligase inhibitor	Bio-AMS is a potent bacterial biotin protein ligase (BPL) inhibitor, possesses selective activity against Mycobacterium tuberculosis (Mtb) and inhibits fatty acid and lipid biosynthesis.
PC-23766	MtbFadD32 inhibitor M1 Mtb FadD32 inhibitor	MtbFadD32 inhibitor M1 is a small molecule inhibitor of Mycobacterium tuberculosis fatty acyl-AMP ligase FadD32 and FadD28, shows specific antitubercular activity with IC50 of 4.8 ug/mL, binds and inhibits the FAAL activity of MtbFadD32 and MtbFadD28 enzymes.
PC-23757	STK848198 FtsH inhibitor	STK848198 is a small molecule antimicrobial compound with MIC of 2 ug/mL against S. aureus by targeting ATP‐binding protein FtsH, inhibits methicillin‐sensitive S. aureus, MSRA, VAN intermediate S. aureus (VISA), and DAP‐resistant strains with MIC ranged from 0.5 to 8 ug/mL.
PC-23656	Evybactin M.tb DNA gyrase inhibitor	Evybactin is a potent and selective antibiotic acting against M. tuberculosis (MIC=0.25 ug/mL) targeting DNA gyrase.
PC-23591	Miltefosine 58066-85-6	Miltefosine is a phosphatidylcholine analog with anti-leishmanial activity, inhibits PI3K/Akt activity, shows broad spectrum antimicrobial, anti-leishmanial and anticoronaviral activity.
PC-23552	(R)-ZG197 SaClpP agonist	(R)-ZG197 is a highly selective S. aureus caseinolytic protease P (SaClpP) activator / agonist with EC50 of 1.5 uM and Kd of 58 nM in BLI assays, 20-fold higher activity than that activates HsClpP.
PC-23551	ZG297 SaClpP agonist	ZG297 is a potent, selective S. aureus caseinolytic protease P (SaClpP) agonist with EC50 of 0.26 uM, without activity against Homo sapiens ClpP (HsClpP) (IC50>100 uM), exerts SaClpP-dependent antistaphylococcal activity.
PC-23524	REP8839 MetRS inhibitor	REP8839 (Bederocin) is a potent inhibitor of S. aureus methionyl-tRNA synthetase (MetRS) with IC50 of <1.9 nM.
PC-23523	DDD806905 MetRS inhibitor	DDD806905 is a highly potent, selective inhibitor of Leishmania donovani methionyl-tRNA synthetase (LdMetRS) with Ki of 18 nM.

PREV 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 232425 26 27 28 29 30 31 32 33 34 NEXT

Request The Product List ofBacterial Bacterial

Request The Product List

* Indicates a Required FieldYour information is safe with us.